Safety evaluation of immune checkpoint inhibitors combined with chemotherapy for the treatment of small cell lung cancer: A meta‐analysis of randomized controlled trials

Safety evaluation of immune checkpoint inhibitors combined with chemotherapy for the treatment of small cell lung cancer: A meta‐analysis of randomized controlled trials

Abstract Background The addition of immune checkpoint inhibitors (ICIs) to chemotherapy is the new standard of care in the first‐line treatment of small cell lung cancer (SCLC). However, although the concomitant use of immunotherapy and chemotherapy can increase the antitumor efficacy, it can also i...

Full description

Bibliographic Details
Main Authors: Vito Longo, Alessandro Rizzo, Annamaria Catino, Michele Montrone, Domenico Galetta
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:Thoracic Cancer
Subjects:
immune checkpoint inhibitors
immunotherapy
meta‐analysis
safety
SCLC
Online Access:https://doi.org/10.1111/1759-7714.14842

Similar Items

Similar Items